Hua Medicine (Shanghai) Ltd.
Hua Medicine (Shanghai) Ltd. (HUMDF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · HUMDF · as of Jun 9, 2026
Key Statistics
Explore Hua Medicine (Shanghai) Ltd. Data
humdf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
humdf competitorsHUMDF
AGYTF
BOIRF
CLVLY
CRLBF
HNSBFStock Performance
Full HistoryAbout Hua Medicine (Shanghai) Ltd.
Hua Medicine (Shanghai) Ltd. is a clinical-stage pharmaceutical firm specializing in treatments for diabetes, primarily targeting the Chinese market. Its flagship product is Dorzagliatin (also known a…
what is hua medicine (shanghai) ltd. · humdf stock overview · hua medicine (shanghai) ltd. company profile · who is hua medicine (shanghai) ltd. ceo · humdf OTC · hua medicine (shanghai) ltd. headquarters · hua medicine (shanghai) ltd. business segments
About Stock Overview & Key Data
Hua Medicine (Shanghai) Ltd. (HUMDF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Mar 15, 2021. As of the latest trading session, HUMDF stock price is $0.41, with a market capitalization of $409.3M. The stock has returned +173.80% over the past 12 months and +0.00% year-to-date.
In fiscal year 2025, Hua Medicine (Shanghai) Ltd. reported revenue of $480.2M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Hua Medicine (Shanghai) Ltd. (HUMDF) stock price is $0.41. The stock is traded on OTC under the ticker symbol HUMDF. The 52-week range is $0.15 – $0.50.